Pregled bibliografske jedinice broj: 1157921
Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research
Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research // International journal of molecular sciences, 22 (2021), 9106-18 doi:10.3390/ijms22179106 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1157921 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research
Autori
Štambuk, Nikola ; Konjevoda, Paško ; Pavan, Josip
Izvornik
International journal of molecular sciences (1422-0067) 22
(2021);
9106-18
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
antisense ; complementary ; peptide ; binding ; genetic code ; technology ; bioengineering ; SARS-CoV-2
Sažetak
Antisense peptide technology (APT) is based on a useful heuristic algorithm for rational peptide design. It was deduced from empirical observations that peptides consisting of complementary (sense and antisense) amino acids interact with higher probability and affinity than the randomly selected ones. This phenomenon is closely related to the structure of the standard genetic code table, and at the same time, is unrelated to the direction of its codon sequence translation. The concept of complementary peptide interaction is discussed, and its possible applications to diagnostic tests and bioengineering research are summarized. Problems and difficulties that may arise using APT are discussed, and possible solutions are proposed. The methodology was tested on the example of SARS-CoV-2. It is shown that the CABS-dock server accurately predicts the binding of antisense peptides to the SARS-CoV-2 receptor binding domain without requiring predefinition of the binding site. It is concluded that the benefits of APT outweigh the costs of random peptide screening and could lead to considerable savings in time and resources, especially if combined with other computational and immunochemical methods.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti, Kliničke medicinske znanosti, Interdisciplinarne biotehničke znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE